×
Atai Life Sciences EBIT 2020-2025 | ATAI
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Atai Life Sciences ebit from 2020 to 2025. Ebit can be defined as earnings before interest and taxes.
View More
Atai Life Sciences EBIT 2020-2025 | ATAI
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Atai Life Sciences ebit from 2020 to 2025. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Quest Diagnostics (DGX)
$18.9B
Encompass Health (EHC)
$11.1B
DaVita (DVA)
$10.9B
Elanco Animal Health (ELAN)
$7B
Chemed (CHE)
$6.1B
Option Care Health (OPCH)
$5B
RadNet (RDNT)
$4.3B
Amedisys (AMED)
$3.2B
Addus HomeCare (ADUS)
$2B
LifeStance Health (LFST)
$1.6B
Astrana Health (ASTH)
$1.3B
U.S Physical Therapy (USPH)
$1.1B
Aveanna Healthcare Holdings (AVAH)
$778M
Pennant (PNTG)
$778M
Daxor (DXR)
$48M
MEDIROM Healthcare Technologies (MRM)
$35M
Ontrak (OTRK)
$2M
Psychemedics (PMD)
$0M